Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Sonoma Pharmaceuticals, Inc. (SNOA) had Free Cash Flow per Share of $-0.14 for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
$14.29M |
|
$-3.46M |
|
$8.82M |
|
$5.46M |
|
$18.00M |
|
$-3.71M |
|
$0.80M |
|
$-2.91M |
|
$-2.91M |
|
$-3.46M |
|
$-3.46M |
|
$-3.46M |
|
$-3.46M |
|
$-3.71M |
|
$-3.57M |
|
1.24M |
|
1.24M |
|
$-2.79 |
|
$-2.79 |
|
| Balance Sheet Financials | |
$12.65M |
|
$0.23M |
|
$1.04M |
|
$13.69M |
|
$4.10M |
|
-- |
|
$5.19M |
|
$9.28M |
|
$4.41M |
|
$4.41M |
|
$4.41M |
|
1.63M |
|
| Cash Flow Statement Financials | |
$-0.09M |
|
$-0.08M |
|
$3.03M |
|
$3.13M |
|
$5.37M |
|
$2.25M |
|
$0.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.09 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
38.25% |
|
-25.97% |
|
-25.97% |
|
-25.00% |
|
-20.35% |
|
-24.20% |
|
$-0.17M |
|
-- |
|
-- |
|
-- |
|
1.04 |
|
3.03 |
|
6.40 |
|
57.02 |
|
-78.37% |
|
-78.37% |
|
-25.25% |
|
-78.37% |
|
$2.70 |
|
|
Free Cash Flow per Share |
$-0.14 |
$-0.07 |
|